1
|
Ajibo DN, Orish CN, Ruggieri F, Bocca B, Battistini B, Frazzoli C, Orish FC, Orisakwe OE. An Update Overview on Mechanistic Data and Biomarker Levels in Cobalt and Chromium-Induced Neurodegenerative Diseases. Biol Trace Elem Res 2024; 202:3538-3564. [PMID: 38017235 DOI: 10.1007/s12011-023-03965-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/06/2023] [Accepted: 11/12/2023] [Indexed: 11/30/2023]
Abstract
There is increasing evidence that the imbalance of metals as cobalt (Co) and chromium (Cr) may increase the risk of development and progression of neurodegenerative diseases (NDDs). The human exposure to Co and Cr is derived mostly from industry, orthopedic implants, and polluted environments. Neurological effects of Co and Cr include memory deficit, olfactory dysfunction, spatial disorientation, motor neuron disease, and brain cancer. Mechanisms of Co and Cr neurotoxicity included DNA damage and genomic instability, epigenetic changes, mitochondrial disturbance, lipid peroxidation, oxidative stress, inflammation, and apoptosis. This paper seeks to overview the Co and Cr sources, the mechanisms by which these metals induce NDDs, and their levels in fluids of the general population and patients affected by NDDs. To this end, evidence of Co and Cr unbalance in the human body, mechanistic data, and neurological symptoms were collected using in vivo mammalian studies and human samples.
Collapse
Affiliation(s)
- Doris Nnena Ajibo
- Department of Experimental Pharmacology & Toxicology, Faculty of Pharmacy, University of Port Harcourt, PMB, 5323, Port Harcourt, Rivers State, Nigeria
| | - Chinna Nneka Orish
- Department of Anatomy, College of Health Sciences University of Port Harcourt, PMB, 5323, Port Harcourt, Rivers State, Nigeria
| | - Flavia Ruggieri
- Department of Environment and Health, Istituto Superiore Di Sanità, Rome, Italy
| | - Beatrice Bocca
- Department of Environment and Health, Istituto Superiore Di Sanità, Rome, Italy
| | - Beatrice Battistini
- Department of Environment and Health, Istituto Superiore Di Sanità, Rome, Italy
| | - Chiara Frazzoli
- Department for Cardiovascular, Endocrine-Metabolic Diseases, and Aging, Istituto Superiore Di Sanità, Rome Viale Regina Elena, 29900161, Rome, Italy
| | | | - Orish E Orisakwe
- Department of Experimental Pharmacology & Toxicology, Faculty of Pharmacy, University of Port Harcourt, PMB, 5323, Port Harcourt, Rivers State, Nigeria.
- African Centre of Excellence for Public Health and Toxicological Research (ACE-PUTOR), University of Port Harcourt, PMB, 5323, Port Harcourt, Rivers State, Nigeria.
| |
Collapse
|
2
|
Bocca B, Battistini B. Biomarkers of exposure and effect in human biomonitoring of metal-based nanomaterials: their use in primary prevention and health surveillance. Nanotoxicology 2024; 18:1-35. [PMID: 38436298 DOI: 10.1080/17435390.2023.2301692] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2023] [Accepted: 12/28/2023] [Indexed: 03/05/2024]
Abstract
Metal-based nanomaterials (MNMs) have gained particular interest in nanotechnology industry. They are used in various industrial processes, in biomedical applications or to improve functional properties of several consumer products. The widescale use of MNMs in the global consumer market has resulted in increases in the likelihood of exposure and risks to human beings. Human exposure to MNMs and assessment of their potential health effects through the concomitant application of biomarkers of exposure and effect of the most commonly used MNMs were reviewed in this paper. In particular, interactions of MNMs with biological systems and the nanobiomonitoring as a prevention tool to detect the early damage caused by MNMs as well as related topics like the influence of some physicochemical features of MNMs and availability of analytical approaches for MNMs testing in human samples were summarized in this review. The studies collected and discussed seek to increase the current knowledge on the internal dose exposure and health effects of MNMs, highlighting the advantages in using biomarkers in primary prevention and health surveillance.
Collapse
Affiliation(s)
- Beatrice Bocca
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| | - Beatrice Battistini
- Department of Environment and Health, Istituto Superiore di Sanità, Rome, Italy
| |
Collapse
|
3
|
Xu H, Shi L, Feng L, Wu F, Chen J, Qin Y, Dong X, Jiang Z, Li Y, Xia H, Lou J. Hexavalent chromium [Cr(VI)]-induced ribosomal DNA copy number variation and DNA damage responses and their associations with nucleolar protein HRAS in humans and cells. ENVIRONMENTAL POLLUTION (BARKING, ESSEX : 1987) 2023:121816. [PMID: 37182578 DOI: 10.1016/j.envpol.2023.121816] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/12/2023] [Revised: 04/06/2023] [Accepted: 05/11/2023] [Indexed: 05/16/2023]
Abstract
The carcinogenicity of hexavalent chromium [Cr(VI)] and its compounds has been widely recognized, yet the mechanism of genetic damage is still not fully understood. The ribosomal DNA (rDNA) copy number is recently considered a potential marker of cancer-associated stress. To investigate the roles of rDNA copy number variation (CNV) in DNA damage responses (DDRs) induced by Cr(VI) and the potential mechanism from nucleolar protein HRAS, a cross-sectional study in Cr(Ⅵ)-exposed workers and an in vitro experiment using HeLa cells were conducted. Our results showed increased levels of rDNA CNV, DDRs, and HRAS expression in Cr(VI)-exposed workers. Generalized linear regression analyses showed that Cr(VI) exposure was significantly positively associated with increased levels of rDNA CNV, DDRs, and HRAS expression in Cr(VI)-exposed workers. Moreover, there were pairwise associations between rDNA CNV, DDRs, and HRAS levels. Mediation analyses found that rDNA CNV significantly mediated the association between Cr(VI) exposure and DDRs. The in vitro experiments further confirmed that Cr(VI) treatment induced increased levels of rDNA CNV, DDRs, and HRAS expression in HeLa cells. Cr(VI)-induced rDNA CNV, ATM activation, and apoptosis damage were then strongly enhanced by HRAS depletion with siRNA in vitro, suggesting the important role of HRAS in CNV and DDRs caused by Cr(VI). The combined results of the human and cell line studies indicated that Cr(VI) exposure might enhance rDNA CNV by regulation of HRAS expression, which leads to Cr(VI)-induced genetic damage.
Collapse
Affiliation(s)
- Huadong Xu
- School of Public Health, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China
| | - Li Shi
- School of Public Health, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China
| | - Lingfang Feng
- School of Public Health, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China
| | - Fan Wu
- School of Public Health, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China
| | - Junfei Chen
- School of Public Health, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China
| | - Yao Qin
- School of Public Health, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China
| | - Xiaowen Dong
- School of Public Health, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China
| | - Zhaoqiang Jiang
- School of Public Health, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China
| | - Yongxin Li
- School of Public Health, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China
| | - Hailing Xia
- School of Public Health, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China
| | - Jianlin Lou
- School of Public Health, Hangzhou Medical College, Hangzhou, Zhejiang, 310013, China; School of Medicine, and the First Affiliated Hospital, Huzhou University, Huzhou, Zhejiang, 313000, China.
| |
Collapse
|
4
|
Vorkamp K, Esteban López M, Gilles L, Göen T, Govarts E, Hajeb P, Katsonouri A, Knudsen LE, Kolossa-Gehring M, Lindh C, Nübler S, Pedraza-Díaz S, Santonen T, Castaño A. Coordination of chemical analyses under the European Human Biomonitoring Initiative (HBM4EU): Concepts, procedures and lessons learnt. Int J Hyg Environ Health 2023; 251:114183. [PMID: 37148759 DOI: 10.1016/j.ijheh.2023.114183] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2023] [Revised: 04/24/2023] [Accepted: 04/26/2023] [Indexed: 05/08/2023]
Abstract
The European Human Biomonitoring Initiative (HBM4EU) ran from 2017 to 2022 with the aim of advancing and harmonizing human biomonitoring in Europe. More than 40,000 analyses were performed on human samples in different human biomonitoring studies in HBM4EU, addressing the chemical exposure of the general population, temporal developments, occupational exposure and a public health intervention on mercury in populations with high fish consumption. The analyses covered 15 priority groups of organic chemicals and metals and were carried out by a network of laboratories meeting the requirements of a comprehensive quality assurance and control system. The coordination of the chemical analyses included establishing contacts between sample owners and qualified laboratories and monitoring the progress of the chemical analyses during the analytical phase, also addressing status and consequences of Covid-19 measures. Other challenges were related to the novelty and complexity of HBM4EU, including administrative and financial matters and implementation of standardized procedures. Many individual contacts were necessary in the initial phase of HBM4EU. However, there is a potential to develop more streamlined and standardized communication and coordination in the analytical phase of a consolidated European HBM programme.
Collapse
Affiliation(s)
- Katrin Vorkamp
- Aarhus University, Department of Environmental Science, Roskilde, Denmark.
| | - Marta Esteban López
- Instituto de Salud Carlos III, National Centre for Environmental Health, Majadahonda, Spain
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research, Mol, Belgium
| | - Thomas Göen
- Friedrich-Alexander Universität Erlangen-Nürnberg, Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Erlangen, Germany
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research, Mol, Belgium
| | - Parvaneh Hajeb
- Aarhus University, Department of Environmental Science, Roskilde, Denmark
| | | | - Lisbeth E Knudsen
- University of Copenhagen, Institute of Public Health, Copenhagen, Denmark
| | | | - Christian Lindh
- Lund University, Division of Occupational and Environmental Medicine, Lund, Sweden
| | - Stefanie Nübler
- Friedrich-Alexander Universität Erlangen-Nürnberg, Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Erlangen, Germany
| | - Susana Pedraza-Díaz
- Instituto de Salud Carlos III, National Centre for Environmental Health, Majadahonda, Spain
| | - Tiina Santonen
- Finnish Institute of Occupational Health, Helsinki, Finland
| | - Argelia Castaño
- Instituto de Salud Carlos III, National Centre for Environmental Health, Majadahonda, Spain
| |
Collapse
|
5
|
Mortada WI, El-Naggar A, Mosa A, Palansooriya KN, Yousaf B, Tang R, Wang S, Cai Y, Chang SX. Biogeochemical behaviour and toxicology of chromium in the soil-water-human nexus: A review. CHEMOSPHERE 2023; 331:138804. [PMID: 37137390 DOI: 10.1016/j.chemosphere.2023.138804] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/01/2023] [Revised: 04/25/2023] [Accepted: 04/27/2023] [Indexed: 05/05/2023]
Abstract
Chromium (Cr) affects human health if it accumulates in organs to elevated concentrations. The toxicity risk of Cr in the ecosphere depends upon the dominant Cr species and their bioavailability in the lithosphere, hydrosphere, and biosphere. However, the soil-water-human nexus that controls the biogeochemical behaviour of Cr and its potential toxicity is not fully understood. This paper synthesizes information on different dimensions of Cr ecotoxicological hazards in the soil and water and their subsequent effects on human health. The various routes of environmental exposure of Cr to humans and other organisms are also discussed. Human exposure to Cr(VI) causes both carcinogenic and non-carcinogenic health effects via complicated reactions that include oxidative stress, chromosomal and DNA damage, and mutagenesis. Chromium (VI) inhalation can cause lung cancer; however, incidences of other types of cancer following Cr(VI) exposure are low but probable. The non-carcinogenic health consequences of Cr(VI) exposure are primarily respiratory and cutaneous. Research on the biogeochemical behaviour of Cr and its toxicological hazards on human and other biological routes is therefore urgently needed to develop a holistic approach to understanding the soil-water-human nexus that controls the toxicological hazards of Cr and its detoxification.
Collapse
Affiliation(s)
- Wael I Mortada
- Urology and Nephrology Center, Mansoura University, Mansoura, 35516, Egypt
| | - Ali El-Naggar
- State Key Laboratory of Subtropical Silviculture, Zhejiang A&F University, Lin'an, 311300, China; Department of Soil Sciences, Faculty of Agriculture, Ain Shams University, Cairo, 11241, Egypt; Department of Renewable Resources, University of Alberta, Edmonton, Alberta, T6G 2H1, Canada
| | - Ahmed Mosa
- Soils Department, Faculty of Agriculture, Mansoura University, Mansoura, 35516, Egypt.
| | | | - Balal Yousaf
- CAS-Key Laboratory of Crust-Mantle Materials and the Environments, School of Earth and Space Sciences, University of Science and Technology of China, Hefei, 230026, China; Department of Environmental Engineering, Middle East Technical University, Ankara, 06800, Turkey
| | - Ronggui Tang
- State Key Laboratory of Subtropical Silviculture, Zhejiang A&F University, Lin'an, 311300, China
| | - Shengsen Wang
- College of Environmental Science and Engineering, Yangzhou University, 196 W Huayang Rd, Yangzhou, Jiangsu, PR China
| | - Yanjiang Cai
- State Key Laboratory of Subtropical Silviculture, Zhejiang A&F University, Lin'an, 311300, China
| | - Scott X Chang
- State Key Laboratory of Subtropical Silviculture, Zhejiang A&F University, Lin'an, 311300, China; Department of Renewable Resources, University of Alberta, Edmonton, Alberta, T6G 2H1, Canada.
| |
Collapse
|
6
|
Santonen T, Mahiout S, Alvito P, Apel P, Bessems J, Bil W, Borges T, Bose-O'Reilly S, Buekers J, Cañas Portilla AI, Calvo AC, de Alba González M, Domínguez-Morueco N, López ME, Falnoga I, Gerofke A, Caballero MDCG, Horvat M, Huuskonen P, Kadikis N, Kolossa-Gehring M, Lange R, Louro H, Martins C, Meslin M, Niemann L, Díaz SP, Plichta V, Porras SP, Rousselle C, Scholten B, Silva MJ, Šlejkovec Z, Tratnik JS, Joksić AŠ, Tarazona JV, Uhl M, Van Nieuwenhuyse A, Viegas S, Vinggaard AM, Woutersen M, Schoeters G. How to use human biomonitoring in chemical risk assessment: Methodological aspects, recommendations, and lessons learned from HBM4EU. Int J Hyg Environ Health 2023; 249:114139. [PMID: 36870229 DOI: 10.1016/j.ijheh.2023.114139] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2022] [Revised: 02/13/2023] [Accepted: 02/14/2023] [Indexed: 03/06/2023]
Abstract
One of the aims of the European Human Biomonitoring Initiative, HBM4EU, was to provide examples of and good practices for the effective use of human biomonitoring (HBM) data in human health risk assessment (RA). The need for such information is pressing, as previous research has indicated that regulatory risk assessors generally lack knowledge and experience of the use of HBM data in RA. By recognising this gap in expertise, as well as the added value of incorporating HBM data into RA, this paper aims to support the integration of HBM into regulatory RA. Based on the work of the HBM4EU, we provide examples of different approaches to including HBM in RA and in estimations of the environmental burden of disease (EBoD), the benefits and pitfalls involved, information on the important methodological aspects to consider, and recommendations on how to overcome obstacles. The examples are derived from RAs or EBoD estimations made under the HBM4EU for the following HBM4EU priority substances: acrylamide, o-toluidine of the aniline family, aprotic solvents, arsenic, bisphenols, cadmium, diisocyanates, flame retardants, hexavalent chromium [Cr(VI)], lead, mercury, mixture of per-/poly-fluorinated compounds, mixture of pesticides, mixture of phthalates, mycotoxins, polycyclic aromatic hydrocarbons (PAHs), and the UV-filter benzophenone-3. Although the RA and EBoD work presented here is not intended to have direct regulatory implications, the results can be useful for raising awareness of possibly needed policy actions, as newly generated HBM data from HBM4EU on the current exposure of the EU population has been used in many RAs and EBoD estimations.
Collapse
Affiliation(s)
| | | | - Paula Alvito
- National Institute of Health Dr. Ricardo Jorge, 1649-016, Lisbon, Portugal; Centre for Environmental and Marine Studies (CESAM), University of Aveiro, 3810-193 Aveiro, Portugal
| | - Petra Apel
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Jos Bessems
- VITO-Flemish Institute for Technological Research, Mol, Belgium
| | - Wieneke Bil
- National Institute for Public Health and the Environment, Bilthoven, the Netherlands
| | - Teresa Borges
- General-Directorate of Health, Ministry of Health, 1049-005, Lisbon, Portugal
| | - Stephan Bose-O'Reilly
- Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - Private University for Health Sciences, Medical Informations und Technology, Hall i.T., Austria
| | - Jurgen Buekers
- VITO-Flemish Institute for Technological Research, Mol, Belgium
| | | | - Argelia Castaño Calvo
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | | | | | - Marta Esteban López
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | | | - Antje Gerofke
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | | | | | | | | | | | - Rosa Lange
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Henriqueta Louro
- National Institute of Health Dr. Ricardo Jorge, 1649-016, Lisbon, Portugal; ToxOmics-Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056, Lisboa, Portugal
| | - Carla Martins
- NOVA National School of Public Health, Public Health Research Centre, NOVA University Lisbon, 1600-560, Lisbon, Portugal; Comprehensive Health Research Center (CHRC), NOVA University Lisbon, 1600-560, Lisbon, Portugal
| | - Matthieu Meslin
- French Agency for Food, Environmental and Occupational Health & Safety, Anses, 14 rue Pierre et Marie Curie, 94701, Maisons-Alfort, France
| | - Lars Niemann
- German Federal Institute for Risk Assessment, Berlin, Germany
| | - Susana Pedraza Díaz
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | - Veronika Plichta
- Austrian Agency for Health and Food Safety, Department Risk Assessment, Spargelfeldstraße 191, 1220, Vienna, Austria
| | | | - Christophe Rousselle
- French Agency for Food, Environmental and Occupational Health & Safety, Anses, 14 rue Pierre et Marie Curie, 94701, Maisons-Alfort, France
| | - Bernice Scholten
- Research Group Risk Analysis for Products in Development, The Netherlands Organisation for Applied Scientific research (TNO), Utrecht, the Netherlands
| | - Maria João Silva
- National Institute of Health Dr. Ricardo Jorge, 1649-016, Lisbon, Portugal; ToxOmics-Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056, Lisboa, Portugal
| | | | | | | | - Jose V Tarazona
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain; European Food Safety Authority (EFSA), Parma, Italy
| | - Maria Uhl
- Environment Agency Austria, Spittelauer Lände 5, 1090, Vienna, Austria
| | | | - Susana Viegas
- NOVA National School of Public Health, Public Health Research Centre, NOVA University Lisbon, 1600-560, Lisbon, Portugal; Comprehensive Health Research Center (CHRC), NOVA University Lisbon, 1600-560, Lisbon, Portugal
| | | | - Marjolijn Woutersen
- National Institute for Public Health and the Environment, Bilthoven, the Netherlands
| | - Greet Schoeters
- VITO-Flemish Institute for Technological Research, Mol, Belgium; University of Antwerp, Dept of Biomedical Sciences, Antwerp, Belgium
| |
Collapse
|
7
|
Tavares A, Aimonen K, Ndaw S, Fučić A, Catalán J, Duca RC, Godderis L, Gomes BC, Janasik B, Ladeira C, Louro H, Namorado S, Nieuwenhuyse AV, Norppa H, Scheepers PTJ, Ventura C, Verdonck J, Viegas S, Wasowicz W, Santonen T, Silva MJ. HBM4EU Chromates Study-Genotoxicity and Oxidative Stress Biomarkers in Workers Exposed to Hexavalent Chromium. TOXICS 2022; 10:483. [PMID: 36006162 PMCID: PMC9412464 DOI: 10.3390/toxics10080483] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/30/2022] [Revised: 08/13/2022] [Accepted: 08/17/2022] [Indexed: 06/15/2023]
Abstract
A study was conducted within the European Human Biomonitoring Initiative (HBM4EU) to characterize occupational exposure to Cr(VI). Herein we present the results of biomarkers of genotoxicity and oxidative stress, including micronucleus analysis in lymphocytes and reticulocytes, the comet assay in whole blood, and malondialdehyde and 8-oxo-2′-deoxyguanosine in urine. Workers from several Cr(VI)-related industrial activities and controls from industrial (within company) and non-industrial (outwith company) environments were included. The significantly increased genotoxicity (p = 0.03 for MN in lymphocytes and reticulocytes; p < 0.001 for comet assay data) and oxidative stress levels (p = 0.007 and p < 0.001 for MDA and 8-OHdG levels in pre-shift urine samples, respectively) that were detected in the exposed workers over the outwith company controls suggest that Cr(VI) exposure might still represent a health risk, particularly, for chrome painters and electrolytic bath platers, despite the low Cr exposure. The within-company controls displayed DNA and chromosomal damage levels that were comparable to those of the exposed group, highlighting the relevance of considering all industry workers as potentially exposed. The use of effect biomarkers proved their capacity to detect the early biological effects from low Cr(VI) exposure, and to contribute to identifying subgroups that are at higher risk. Overall, this study reinforces the need for further re-evaluation of the occupational exposure limit and better application of protection measures. However, it also raised some additional questions and unexplained inconsistencies that need follow-up studies to be clarified.
Collapse
Affiliation(s)
- Ana Tavares
- Department of Human Genetics, National Institute of Health Dr. Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal
| | - Kukka Aimonen
- Finnish Institute of Occupational Health, 00250 Helsinki, Finland
| | - Sophie Ndaw
- French National Research and Safety Institute, 54500 Vandœuvre-lès-Nancy, France
| | - Aleksandra Fučić
- Institute for Medical Research and Occupational Health, Ksaverska Cesta 2, HR-10001 Zagreb, Croatia
| | - Julia Catalán
- Finnish Institute of Occupational Health, 00250 Helsinki, Finland
- Department of Anatomy Embryology and Genetics, University of Zaragoza, 50013 Zaragoza, Spain
| | - Radu Corneliu Duca
- Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), O&N 5b, Herestraat 49, P.O. Box 952, 3000 Leuven, Belgium
- Department of Health Protection, Laboratoire National de Santé (LNS), 3555 Dudelange, Luxembourg
| | - Lode Godderis
- Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), O&N 5b, Herestraat 49, P.O. Box 952, 3000 Leuven, Belgium
- IDEWE, External Service for Prevention and Protection at Work, 3001 Heverlee, Belgium
| | - Bruno C. Gomes
- Centre for Toxicogenomics and Human Health (Toxomics), NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056 Lisbon, Portugal
| | - Beata Janasik
- Department of Environmental and Biological Monitoring, Nofer Institute of Occupational Medicine, 91348 Lodz, Poland
| | - Carina Ladeira
- HTRC—Health & Technology Research Center, ESTeSL—Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, 1549-020 Lisbon, Portugal
| | - Henriqueta Louro
- Department of Human Genetics, National Institute of Health Dr. Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal
- Centre for Toxicogenomics and Human Health (Toxomics), NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056 Lisbon, Portugal
| | - Sónia Namorado
- Department of Human Genetics, National Institute of Health Dr. Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal
| | - An Van Nieuwenhuyse
- Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), O&N 5b, Herestraat 49, P.O. Box 952, 3000 Leuven, Belgium
- Department of Health Protection, Laboratoire National de Santé (LNS), 3555 Dudelange, Luxembourg
| | - Hannu Norppa
- Finnish Institute of Occupational Health, 00250 Helsinki, Finland
| | - Paul T. J. Scheepers
- Radboud Institute for Health Sciences, Radboudumc, 6500 HB Nijmegen, The Netherlands
| | - Célia Ventura
- Department of Human Genetics, National Institute of Health Dr. Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal
- Centre for Toxicogenomics and Human Health (Toxomics), NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056 Lisbon, Portugal
| | - Jelle Verdonck
- Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven (University of Leuven), O&N 5b, Herestraat 49, P.O. Box 952, 3000 Leuven, Belgium
| | - Susana Viegas
- NOVA National School of Public Health, Universidade NOVA de Lisboa, 1600-560 Lisbon, Portugal
- Comprehensive Health Research Center (CHRC), 1169-056 Lisbon, Portugal
| | - Wojciech Wasowicz
- Department of Environmental and Biological Monitoring, Nofer Institute of Occupational Medicine, 91348 Lodz, Poland
| | - Tiina Santonen
- Finnish Institute of Occupational Health, 00250 Helsinki, Finland
| | - Maria João Silva
- Department of Human Genetics, National Institute of Health Dr. Ricardo Jorge (INSA), Av. Padre Cruz, 1649-016 Lisbon, Portugal
- Centre for Toxicogenomics and Human Health (Toxomics), NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056 Lisbon, Portugal
| | | |
Collapse
|